This 60 Minutes segment on Trasylol is yet another glaring example of how warnings about the adverse effects of a drug can get pushed aside and buried by a pharmaceutical company seemingly more interested in profits than saving lives. Meanwhile the Food and Drug Administration does little to hold Bayer accountable for not releasing the results of a study that would have shown Trasyol was linked to kidney failure in patients.
60 Minutes: Drug linked to thousands of deaths; warnings went unheeded
February 18, 2008 by Joe Newman
One Response
Follow Our Tweets!
Tweets by Public_CitizenSupport Our Work
Socialize With Us
Categories
Visit Our Other Sites
Public Citizen Read our reports and publications
Eyes on Trade Challenging globalization
Citizen Energy Fighting for a sustainable future
Law & Policy Justice for consumers
Texas Vox Activism from the Lone Star state
Worst Pills An independent pharma watchdog
Recent Comments
Flickr Photos
- access to justice Activism arbitration Avandia bailout banking big oil big pharma BP campaign contributions Campaign Finance campaign finance reform Chamber of Commerce Citizens United Citizens United v. FEC Climate Change Congress Consumer Protection corporate power credit cards DISCLOSE Act Don't Get Rolled economics economy elections Energy energy & climate EPA Ethics fair trade FDA fec financial reform first amendment free trade global warming gop government reform gulf of mexico Halliburton Health health & safety health care health care delivery health care reform Jon Stewart Lobbying lobbying and government ethics lobbyists McCain-Feingold medical malpractice money in politics nafta obama offshore drilling oil oil spill oilspill Open Government petition pharma political ads political advertising political contributions politics Rally to Restore Sanity scotus single-payer stephen colbert Supreme Court Transparency Transportation U.S. Chamber of Commerce wall street wto
Archives
Meta
citizenvox.wordpress.com 
[…] by Joe Newman Seems like 60 Minutes’ report on the deaths linked to the drug Trasylol, which I blogged about earlier, made the air just days before the New England Journal of Medicine published its own look at the […]